Johnny Högberg new CEO of Flemingsberg Science

On 1st November, Johnny Högberg will take over as Chief Executive Officer of the Flemingsberg Science Foundation.

The Foundation’s task is to develop southern Stockholm where clinical care and research are already strongly established with world-leading Karolinska University Hospital, the Karolinska Institute, the Royal Institute of Technology (KTH), Södertörn University and several other academies. Flemingsberg Science will contribute to making the Stockholm region one of the five leading Life Science regions in the world.

Johnny Högberg comes from Skellefteå Science City, where he was CEO, and replaces Björn Varnestig, who is giving up his post as CEO in connection with his 65th birthday.

“I am really looking forward to taking on the role of CEO of Flemingsberg Science. The Stockholm region is a strong area of growth in Europe with high ambitions for Life Science in particular. The fact that the region has the stated goal of attracting the EU’s new Health Emergency Preparedness and Response Authority (HERA) is one of several examples of how these ambitions are expressed in practice,” says Johnny Högberg, incoming CEO of Flemingsberg Science.

The foundation’s Chair, Financial Region Councillor Irene Svenonius (M), is pleased with the recruitment of the new CEO.

“We want to improve conditions for growth and development in Flemingsberg and the surrounding area. This will take place in a broad collaboration between the academies, municipalities and the regional authority, with both healthcare and expanded public transport. To achieve our high goals of attracting new companies, EU authorities, headquarters, investments and research, we need people with Johnny’s experience and knowledge,” says Irene Svenonius.

The Life Science business of Merck KGaA, Darmstadt, Germany Becomes a Trusted Partner of the Flemingsberg Science Foundation

The Life Science business of Merck KGaA, Darmstadt, Germany, and Flemingsberg Science Foundation collaborate to promote Life Science sector in Flemingsberg. This strategic partnership aims to strengthen development of ATMP (Advanced Therapy Medicinal Products).

Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future

In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.

Touchdown Novum Labs for Hydromars!

A new company has arrived in Flemingsberg, and they´re moving at rocket speed on their journey toward space. Meet Hydromars, the startup company developing a system for water purification and nutrient recovery, with a grand goal of enabling sustainable human presence in space.